Laudanno O M
Division of Gastroenterology, University School of Medicine, Rosario, Argentina.
Am J Med. 1987 Nov 20;83(5A):43-7. doi: 10.1016/0002-9343(87)90850-3.
The administration of oral S-adenosylmethionine (SAMe) (100 mg/kg body weight) was well tolerated by the rat gastroduodenal tract. Moreover, rats given SAMe exhibited a significant increase in non-protein sulfhydryl groups of gastroduodenal mucosa as compared with control animals. The abilities of SAMe and misoprostol, a prostaglandin E1 analogue, to protect the gastric mucosa against necrosis induced by various noxious stimuli (ethanol, aspirin, stress) were also compared in standardized, experimental rat models. Pretreatment with SAMe or misoprostol significantly and to the same extent reduced gastric mucosal injury. The experiments described herein indicate that SAMe, a molecule used for the treatment of osteoarthritis, can exert a gastric cytoprotective effect in animals. As preliminary data have shown that this effect may also be reproduced in humans, SAMe seems to provide a therapeutic advantage, in contrast to currently available nonsteroidal anti-inflammatory agents.
大鼠胃肠道对口服S-腺苷甲硫氨酸(SAMe)(100毫克/千克体重)耐受性良好。此外,与对照动物相比,给予SAMe的大鼠胃十二指肠黏膜中非蛋白质巯基显著增加。在标准化的实验大鼠模型中,还比较了SAMe和前列腺素E1类似物米索前列醇保护胃黏膜免受各种有害刺激(乙醇、阿司匹林、应激)诱导坏死的能力。用SAMe或米索前列醇预处理可显著且同等程度地减轻胃黏膜损伤。本文所述实验表明,用于治疗骨关节炎的分子SAMe可在动物体内发挥胃细胞保护作用。由于初步数据表明这种作用在人类中也可能重现,与目前可用的非甾体抗炎药相比,SAMe似乎具有治疗优势。